Haleon (HLNCF) Non-Current Debt (2021 - 2025)
Haleon (HLNCF) recorded quarterly Non-Current Debt of $10.3 billion in Q4 2025, down 6.76% on a QoQ basis from $11.1 billion in Q4 2024, and down 6.76% year-over-year from $11.1 billion in Q4 2024.
Haleon (HLNCF) Non-Current Debt (2021 - 2025) Analysis & Trends
Haleon has disclosed Non-Current Debt across 5 years of filings, most recently posting $10.3 billion for Q4 2025.
- Quarterly Non-Current Debt fell 6.76% year-over-year to $10.3 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 billion (down 6.76% YoY) and the FY2025 annual result came in at $10.2 billion, down 7.2% from the prior year.
- Non-Current Debt eased to $10.3 billion in Q4 2025, from $11.1 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $11.7 billion in Q4 2022 and troughed at -$11.9 billion in Q2 2023.
- A 5-year average of $3.0 billion and a median of $10.3 billion in 2025 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt surged 9904.36% — and 2023, when it fell 7.12%.
- Tracing HLNCF's Non-Current Debt over 5 years: stood at $117.3 million in 2021, then jumped by 9904.36% to $11.7 billion in 2022, then fell by 6.91% to $10.9 billion in 2023, then increased by 1.53% to $11.1 billion in 2024, then decreased by 6.76% to $10.3 billion in 2025.
- Business Quant data shows HLNCF's Non-Current Debt at $10.3 billion in Q4 2025, $11.1 billion in Q4 2024, and $10.9 billion in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Haleon | - | - | - | 10.34 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.34 Bn |
| Dec 31, 2025 | 10.34 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Dec 31, 2024 | 11.09 Bn |
| Dec 31, 2023 | 10.92 Bn |
| Dec 31, 2023 | 10.92 Bn |
| Jun 30, 2023 | -11.92 Bn |
| Jun 30, 2023 | -11.92 Bn |
| Dec 31, 2022 | 11.73 Bn |
| Dec 31, 2022 | 11.73 Bn |
| Jun 30, 2022 | -11.13 Bn |
| Jun 30, 2022 | -11.13 Bn |
| Dec 31, 2021 | 117.28 Mn |
| Dec 31, 2021 | 117.28 Mn |